Type II caesarean scar pregnancy management by ultrasound-guided local lauromacrogol injection in combination with suction curettage: A case report

• Published in: Medicine (Baltimore) 2020-04, Vol.99 (17), p.e19743-e19743
• Main Authors: Wei, Shuang-shuang, Li, Ding-heng, Zhang, Zhi-fen, Sun, Wen-chao, Jia, Cen-lin
• Format: Article
• Language: English
• Subjects: Adult; Cesarean Section - adverse effects; Cesarean Section - methods; Cicatrix - complications; Clinical Case Report; Female; Humans; Polidocanol - therapeutic use; Pregnancy; Pregnancy Complications - drug therapy; Pregnancy Complications - surgery; Ultrasonography - methods; Vacuum Curettage - methods
• ISSN: 0025-7974; 1536-5964; 1536-5964
• DOI: 10.1097/MD.0000000000019743

The implantation of a gestational sac within the scar of a previous caesarean delivery is defined as caesarean scar pregnancy (CSP), which is classified into two types: CSP I and CSP II. CSP II is life threatening, and no clear consensus for CSP II management exists. A 31-year-old woman, gravida 1, para 1, with a previous caesarean delivery due to macrosomia, presented with an estimated 45 days of amenorrhea. The patient presented to the emergency department with vaginal bleeding for 1 day and no abdominal pain. An ultrasound examination was performed demonstrating a viable fetus that was embedded in the caesarean scar area and was bulging through the wall of the uterus into the bladder without contact with the uterine cavity or cervical canal. A diagnosis of type II caesarean scar pregnancy was made. Local lauromacrogol was used to reduce the gestational sac blood supply. Suction curettage was performed under the guidance of abdominal ultrasound 24 h later, and the amount of bleeding was 20 mL. The response to the treatment was monitored by serial beta-human chorionic gonadotropin (β-hCG). Patient was followed up with β-hCG weekly levels which became